CVSI
CV Sciences, Inc.
OTCHealthcareDrug Manufacturers - Specialty & GenericUS
Rating:D+
Company Profile
CEO
Joseph D. Dowling
IPO Date
2013-02-12
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
OTC
Country
US
CV Sciences, Inc.
CEO
Joseph D. Dowling
IPO Date
2013-02-12
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
OTC
Country
US
| 2,350,000 |
| $0.04 |
| 24 Jun 2024 | Dowling Joseph D | director, officer: Chief Executive Officer | A-Award | Acquired | 3,000,000 | $0.05 |
| 24 Jun 2024 | Grasser Joerg | Chief Financial Officer | A-Award | Acquired | 2,350,000 | $0.05 |
| 17 Mar 2023 | Dowling Joseph D | director, officer: CEO | A-Award | Acquired | 2,500,000 | $0.04 |
| 17 Mar 2023 | Grasser Joerg | CFO | A-Award | Acquired | 1,250,000 | $0.04 |
| 1 Apr 2022 | Dowling Joseph D | CEO | D-Return | Disposed | 100,000 | $0.00 |
| 1 Apr 2022 | Dowling Joseph D | director, officer: CEO | D-Return | Disposed | 1,500,000 | $0.33 |
| 1 Apr 2022 | Dowling Joseph D | director, officer: CEO | D-Return | Disposed | 1,500,000 | $0.59 |
| 1 Apr 2022 | Dowling Joseph D | director, officer: CEO | D-Return | Disposed | 500,000 | $0.66 |